(Q53229881)

12 May 2018

title

Postoperative whole abdominal radiotherapy in clear cell adenocarcinoma of the ovary. (English)

1 reference

12 May 2018

adaptive radiation therapy

main subject

0 references

adenocarcinoma

1 reference

based on heuristic

inferred from title

clear cell adenocarcinoma

1 reference

Yutaka Nagai

1

1 reference

12 May 2018

Morihiko Inamine

2

1 reference

12 May 2018

Makoto Hirakawa

3

1 reference

12 May 2018

Kazuya Kamiyama

4

1 reference

12 May 2018

Kazuhiko Ogawa

5

1 reference

12 May 2018

Takafumi Toita

6

1 reference

12 May 2018

Sadayuki Murayama

7

1 reference

12 May 2018

Yoichi Aoki

8

1 reference

12 May 2018

language of work or name

English

0 references

publication date

31 August 2007

1 reference

12 May 2018

published in

Gynecologic Oncology

1 reference

12 May 2018

volume

107

1 reference

12 May 2018

issue

3

1 reference

12 May 2018

page(s)

469-473

1 reference

12 May 2018

Adjuvant therapy in stage I and stage II epithelial ovarian cancer. Results of two prospective randomized trials

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.07.079

Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.07.079

Evaluation of complete surgical staging with pelvic and para-aortic lymphadenectomy and paclitaxel plus carboplatin chemotherapy for improvement of survival in stage I ovarian clear cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.07.079

Irinotecan hydrochloride (CPT-11) and mitomycin C as the first line chemotherapy for ovarian clear cell adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.07.079

Abdominopelvic radiotherapy in ovarian cancer. A 10-year experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.07.079

Randomized study of whole-abdomen irradiation versus pelvic irradiation plus cyclophosphamide in treatment of early ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.07.079

Analysis of complications in patients treated with abdomino-pelvic radiation therapy for ovarian carcinoma

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.07.079

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.07.079

inferred from DOI database lookup

7 January 2021

based on heuristic

A randomized study of two doses of abdominopelvic radiation therapy for patients with optimally debulked stage I, II, and III ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.07.079

Consolidation radiotherapy after carboplatin-based chemotherapy in radically operated advanced ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.07.079

Consolidation treatment of advanced (FIGO stage III) ovarian carcinoma in complete surgical remission after induction chemotherapy: a randomized, controlled, clinical trial comparing whole abdominal radiotherapy, chemotherapy, and no further treatme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.07.079

Epithelial ovarian cancer: the role of radiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.07.079

10.1016/J.YGYNO.2007.07.079

7 January 2021

Identifiers

DOI

1 reference

12 May 2018

1 reference

12 May 2018